Related content

Allelic imbalance at loci containing FGFR, FGF, c-Met and HGF candidate genes in non-small cell lung cancer sub-types, implication for progression

By Beau-Faller M.   Gaub M.P.   Schneider A.   Guerin E.   Meyer N.   Ducrocq X.   Massard G.   Gasser B.   Kessler R.   Weitzenblum E.   Wihlm J.M.   Quoix E.   Oudet P.  

European Journal of Cancer, Vol. 39, Iss. 17, 2003-11 ,pp. : 2538-2547

Elsevier

Access to resources Recommend Favorite

Gene amplification of EGFR, HER2, FGFR2 and MET in esophageal squamous cell carcinoma

By Kato Hiroaki   Arao Tokuzo   Matsumoto Kazuko   Fujita Yoshihiko   Kimura Hideharu   Hayashi Hidetoshi   Nishiki Kouhei   Iwama Mitsuru   Shiraishi Osamu   Yasuda Atsushi   Shinkai Masayuki   Imano Motohiro   Imamoto Haruhiko   Yasuda Takushi   Okuno Kiyotaka   Shiozaki Hitoshi   Nishio Kazuto  

International Journal of Oncology, Vol. 42, Iss. 4, 2013-04 ,pp. : 1151-1158

Spandidos Publications

Access to resources Recommend Favorite

EGFR and K-RAS mutations and ERCC1, TUBB3, TYMS, RRM1 and EGFR mRNA expression in nonsmall cell lung cancer: Correlation with clinical response to gefitinib or chemotherapy

By                    

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1123-1128

Science Publishers

Access to resources Recommend Favorite

Assessment of EGFR and K-ras mutations in fixed and fresh specimens from transesophageal ultrasound-guided fine needle aspiration in non-small cell lung cancer patients

By                        

International Journal of Oncology, Vol. 41, Iss. 1, 2012-01 ,pp. : 147-152

Spandidos Publications

Access to resources Recommend Favorite

Synergistic cell growth inhibition by the combination of amrubicin and Akt-suppressing agents in K-ras mutation-harboring lung adenocarcinoma cells: Implication of EGFR tyrosine kinase inhibitors

By                            

International Journal of Oncology, Vol. 44, Iss. 3, 2014-01 ,pp. : 685-692

Spandidos Publications

Access to resources Recommend Favorite